Perioperative management of patients receiving oral anticoagulation;Management der oralen antikoagulation bei operationen und anderen invasiven eingriffen

Journal fur Kardiologie

Volumn 16, Issue 11-12, 2009, Pages 417-421

  Rammer, Martin ^a   Punzengruber, C ^a   Weber, T ^a   Porodko, M ^a   Ammer, M ^a   Lassnig E ^a   Eber, B ^a  

^a Klinikum Wels Grieskirchen GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; MOUTHWASH; PHENPROCOUMON; TRANEXAMIC ACID; WARFARIN;

AGE; ANTICOAGULANT THERAPY; BLEEDING; CATARACT EXTRACTION; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; GASTROINTESTINAL ENDOSCOPY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VALVE PROSTHESIS; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MAJOR SURGERY; MINOR SURGERY; ORAL SURGERY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM; TOOTH EXTRACTION; TRANSIENT ISCHEMIC ATTACK;

EID: 75149194468     PISSN: 10240098     EISSN: 1680936X     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506-11.
2. White RH, Kaatz S, Douketis J, et al. Comparison of the 30-day incidence of ischemic stroke and bleeding after major surgery in patients with or without atrial fibrillation (AF). J Thromb Haemost 2007; 5 (Suppl 1): O-M-035.
3. Torn M, Rosendaal FR. Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol 2003; 123: 676-82.
4. Borea G, Montebugnoli L, Capuzzi P, Magelli C. Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery. An alternative method to discontinuing anticoagulant therapy. Oral Surg Oral Med Oral Pathol 1993; 75: 29-31.
5. Evans IL, Sayers MS, Gibbons AJ, Price G, Snooks H, Sugar AW. Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Br J Oral Maxillofac Surg 2002; 40: 248-52.
6. Sacco R, Sacco M, Carpenedo M, Moia M. Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets. J Thromb Haemost 2006; 4: 688-9.
7. Billingsley EM, Maloney ME. Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal antiinflammatory agents. A prospective study. Dermatol Surg 1997; 23: 381-3.
8. Alcalay J. Cutaneous surgery in patients receiving warfarin therapy. Dermatol Surg 2001; 27: 756-8.
9. Kargi E, Babuccu O, Hosnuter M, Babuccu B, Altinyazar C. Complications of minor cutaneous surgery in patients under anticoagulant treatment. Aesthetic Plast Surg 2002; 26: 483-5.
10. Syed S, Adams BB, Liao W, Pipitone M, Gloster H. A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery. J Am Acad Dermatol 2004; 51: 955-7.
11. Roberts CW, Woods SM, Turner LS. Cataract surgery in anticoagulated patients. J Cataract Refract Surg 1991; 17: 309-12.
12. Rotenstreich Y, Rubowitz A, Segev F, Jaeger-Roshu S, Assia EI. Effect of warfarin therapy on bleeding during cataract surgery. J Cataract Refract Surg 2001; 27: 1344-6.
13. Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, Fleisher LA, Schein OD; Study of Medical Testing for Cataract Surgery Team. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2003; 110: 1784-8.
14. Wirbelauer C, Weller A, Häberle H, Pham DT. Kataraktoperation in topischer Anästhesie unter oraler Antikoagulation. Klin Monatsbl Augenheilkd 2004; 221: 749-52.
15. Hirschman DR, Morby LJ. A study of the safety of continued anticoagulation for cataract surgery patients. Nurs Forum 2006; 41: 30-7.
16. Gerson LB, Gage BF, Owens DK, Triadafilopoulos G. Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants. Am J Gastroenterol 2000; 95: 1717-24.
17. nd, Waring JP, Fanelli RD, Wheeler-Harbough J; American Society for Gastrointestinal Endoscopy. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002; 55: 775-9.
18. O'Donnell M, Kearon C. Perioperative management of oral anticoagulation. Cardiol Clin 2008; 26: 299-309.
19. th ed). Chest 2008; 133 (6 Suppl): 299S-339S.
20. Helft G, Gilard M, Le Feuvre C, Zaman AG. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Nat Clin Pract Cardiovasc Med 2006; 3: 673-80.
21. Rådegran K, Jyrälä A. Bleeding complications following invasive cardiac studies in anticoagulated patients with artificial heart valves. Scand J Thorac Cardiovasc Surg 1979; 13: 107-9.
22. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-e231.
23. Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J 2009; 157: 132-40.
24. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S; Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006; 27: 1979-2030.
25. Blacker DJ, Wijdicks EF, McClelland RL. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 2003; 61: 964-8.
26. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901-8.
27. Genewein U, Haeberli A, Straub PW, Beer JH. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 1996; 92: 479-85.
28. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 338S-400S.
29. Kimura K, Minematsu K, Yamaguchi T; Japan Multicenter Stroke Investigators' Collaboration (J-MUSIC). Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2005; 76: 679-83.
30. Kaarisalo MM, Immonen-Räihä P, Marttila RJ, Salomaa V, Kaarsalo E, Salmi K, Sarti C, Sivenius J, Torppa J, Tuomilehto J. Atrial fibrillation and stroke. Mortality and causes of death after the first acute ischemic stroke. Stroke 1997; 28: 311-5.
31. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A; Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-68.
32. Spyropoulos AC, Turpie AG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, Frost FJ; REGIMEN Investigators. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost 2006; 4: 1246-52.
33. O'Donnell MJ, Kearon C, Johnson J, Robinson M, Zondag M, Turpie I, Turpie AG. Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin. Ann Intern Med 2007; 146: 184-7.
34. Strebel N, Prins M, Agnelli G, Büller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 2002; 162: 1451-6.
35. Dunn AS, Spyropoulos AC, Turpie AG. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 2007; 5: 2211-8.
36. Watzke H. Management der antithrombotischen Therapie bei Unterbrechung der Therapie mit oralen Antikoagulantion. Journal des BÖI 2002; 15: 7-11.